Immunomic Therapeutics is Drug Discovery in United States that focus on LAMP)-based vaccines business. Founded in 2005. They cover business area such as developer, lysosomal-associate membrane protein, lamp)-based vaccine, immunotherapy, cancer, allergy, animal health, LAMP-Vax, DNA, RNA, an immune response, antibody production, cytokine release, critical immunological memory, health industry.
2005
( 19 years old in 2024 )
LAMP)-based Vaccines
-
15010 Broschart Road
Suite 250
Rockville, MD 20850
United States
Private
developerlysosomal-associate membrane proteinlamp)-based vaccineimmunotherapycancerallergyanimal healthLAMP-VaxDNARNAan immune responseantibody productioncytokine releasecritical immunological memoryhealth industry
* We use standard office opening hours in near Immunomic Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Immunomic Therapeutics is Drug Discovery business from United States that founded in 2005 (19 years old in 2024), Immunomic Therapeutics business is focusing on LAMP)-based Vaccines.
Immunomic Therapeutics headquarter office and corporate office address is located in 15010 Broschart Road Suite 250 Rockville, MD 20850 United States.
Immunomic Therapeutics was founded in United States.
In 2024, Immunomic Therapeutics is currently focus on LAMP)-based vaccines sector.
Above is snippet of Google Trends for "LAMP)-based vaccines" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Immunomic Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.